Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Phase 2 dose-finding trial (Lancet 2021) showed clear dose-response from 0.3 mg up to 4.5 mg/week, but 2.4 mg is the dose Novo Nordisk advanced into Phase 3 and is the most commonly self-reported community ceiling
Understanding this timeline helps set realistic expectations during your first month of treatment
The goal is to help patients improve their overall health, not just their weight or blood sugar levels
Metabolic and energy imbalance in dysglycemia-based chronic disease
doi:10.1016/j.nbd.2024.106684 39
US$ 23.61
US$ 26.93
US$ 22.19
US$ 25.70
US$ 21.47
US$ 21.89
US$ 20.74
US$ 20.91
US$ 21.75
US$ 21.30
US$ 20.54
US$ 22.55
US$ 29.09
US$ 20.72
US$ 20.20
